MBA, University of Utah, 2015
Ph.D., Universidad de Zaragoza, Spain, 2006
B.S. Biochemistry, Universidad de Zaragoza, Spain, 2001

Alberto Bosque, Ph.D., M.B.A., joined the George Washington University in November 2016 as Assistant Professor in the Department of Microbiology, Immunology and Tropical Medicine. He is a biochemist with considerable experience in cell biology and signal transduction. Dr. Bosque received his Bachelor’s degree in Biochemistry with high honors from the University of Zaragoza, Spain in 2001. During his graduate studies at the University of Zaragoza in the laboratory of Dr. Alberto Anel, he studied the mechanisms of downregulation of human T cell immune responses and their implication to Autoimmune Lymphoproliferative Syndromes (ALPS). After obtaining a Ph.D. in Biochemistry and Molecular and Cellular Biology with honors “cum laude”, Dr. Bosque moved to the US and joined the laboratory of Dr. Vicente Planelles at the University of Utah, first with a postdoctoral fellowship from the Spanish Government followed by a Mathilde Krim Postdoctoral Fellowship from The Foundation for AIDS Research (amfAR). During his postdoctoral studies, he developed one of the first primary cell models of HIV-1 latency (Bosque and Planelles, Blood, 2009). In 2011, Dr. Bosque became a Research Assistant Professor at the University of Utah and in 2015 an Assistant Professor. During his time as Faculty at the University of Utah, he also completed with honors a Master Degree in Business Administration (M.B.A.). Dr. Bosque is an Associate Professor in the Department of Microbiology, Immunology & Tropical Medicine at GW. Dr. Bosque has been involved in HIV cure research for the last 15 years focusing on the discovery and characterization of signaling pathways that can both reactivate latent HIV-1 in resting CD4+ T cells and enhance immune effector functions of NK and CD8+ T cells. He has a long-standing funding record as Principal Investigator in HIV cure research, including a Grand Challenges Exploration from the Bill and Melinda Gates Foundation as well as an R21, R21/R33, R56 and two R01s from NIAID, and several other grants as collaborator.

For information, please visit the Bosque Lab website